Cerevel Therapeutics Affiliated Programs
Founded in late 2018 through a partnership with Pfizer and Bain Capital, Cerevel Therapeutics is a clinical-stage biopharmaceutical company that combines a deep understanding of the biology and neurocircuitry of the brain with advanced chemistry and central nervous system receptor pharmacology to discover and develop new therapies.
Cerevel Therapeutics is working relentlessly to find paths through complexity in an effort to bring real progress and new treatment options to people living with a broad range of neuroscience diseases.
The Cerevel Therapeutics and Purdue University Fellowship program is two years in duration and provides the Doctor of Pharmacy graduate with personalized training and direct experience in the biopharmaceutical industry. This fellowship program seeks to develop future leaders in the drug development industry.
Fellowships are available in the following tracks: